Sitemap
- Patient Support
- Products
- Privacy Policy
- Terms & Conditions of Use
- Cookie Policy
- My Account
- Login
- Sitemap
- Campus MY Sanofi Terms of Use
- Campus MY Sanofi PDPN
- Search
- Error 404
- Registration
-
Science
-
Cutting Edge Science
-
Cardiovascular
- General
-
Hypertension
-
2022
-
2023
- Personalized Hypertension Management: Watch Prof. Konstantinos Tsioufis's expert video
- Effect of intensive blood pressure (BP) control treatment on long-term all-cause and cardiovascular (CV) mortality in patients with hypertension
- Comparison of American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension blood pressure/ hypertension guidelines
-
2024
- Effect of ARB-based therapy in hypertensive patients with hyperuricemia and microalbuminuria
- Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in patients with hypertension
- Self-reported single adherence question scored on a visual analogue scale predicts cardiovascular outcomes and mortality
- 2025
-
2022
-
Acute Coronary Syndrome
-
2022
-
2023
-
2024
-
2025
- ACS Management: Insights on Rare Cases and Emerging Predictors
- Clopidogrel: Rethinking Antiplatelet Strategies for Better Outcomes
- Optimizing Hypertension Management: Single-Pill Combinations and Key Insights for Better Outcomes
- Evolving Insights on DAPT and SAPT: Highlights From Recent Key Trials
- Dual Therapy, FCAPs, and Antiplatelets: Recent Evidence You Should Know
- Personalizing Cardiovascular Care in Asian Populations: Insights on Antiplatelet Safety & Lipid Risk
- Personalizing Antiplatelet Therapy: Insights for High-Risk PCI Patients
-
2022
-
Central Nervous System
-
2022
-
2023
- Identifying antipsychotics and/or mood stabilizers for maintenance phase in Bipolar Disorder
- Effect of immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
- CINP Guidelines: Definition and treatment management for resistant bipolar disorder
- Identifying antipsychotics and/or mood stabilizers for maintenance phase in Bipolar Disorder
- World Bipolar Day 2023
- SANAD II trial proves valproate is more clinically effective than levetiracetam in idiopathic generalised epilepsy1
- International Epilepsy Day 2023
- Limiting suicidal risk in bipolar disorders: Suicide cannot be “treated” but can be “prevented”1
- Sudden unexpected death in epilepsy: The role of physiologic effects and clinical factors related to convulsive seizures
-
2022
- Immunology
-
Neurology
-
2023
- High-risk TIA patients under treated with Clopidogrel-Aspirin in emergency setting
- Hear from the expert - Prof Pierre Amarenco on efficiently managing TIA and minor stroke to reduce risk of recurrent stroke
- Dual antiplatelet therapy for treatment of patients with High-Risk transient ischemic attack and Stroke by emergency medicine Physicians: A national survey
- A Caregiver perspective on Bipolar Disorder
- Long-term protection in Antithrombotic treatment after Ischaemic Stroke/ TIA
- Dual Antiplatelet therapy for secondary prevention in ischemic stroke –Trends in prescription patterns after pivotal trials and guideline updates
- 2025
-
2023
- Rare Disease
- Thrombosis
- Vaccines
-
Cardiovascular
- Events
-
Cutting Edge Science
Patient-Video
Request-form
